ETrade Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,890
| Closed | -$973K | – | 890 |
|
|
2020
Q2 | $973K | Buy |
7,890
+2,702
| +52% | +$333K | 0.02% | 358 |
|
|
2020
Q1 | $438K | Buy |
+5,188
| New | +$438K | 0.01% | 500 |
|
|
2019
Q4 | – | Sell |
-4,030
| Closed | -$272K | – | 793 |
|
|
2019
Q3 | $272K | Sell |
4,030
-1,736
| -30% | -$117K | 0.01% | 703 |
|
|
2019
Q2 | $494K | Sell |
5,766
-1,528
| -21% | -$131K | 0.01% | 567 |
|
|
2019
Q1 | $648K | Sell |
7,294
-939
| -11% | -$83.4K | 0.02% | 450 |
|
|
2018
Q4 | $701K | Sell |
8,233
-677
| -8% | -$57.6K | 0.02% | 401 |
|
|
2018
Q3 | $864K | Buy |
8,910
+774
| +10% | +$75.1K | 0.02% | 405 |
|
|
2018
Q2 | $766K | Buy |
8,136
+591
| +8% | +$55.6K | 0.02% | 418 |
|
|
2018
Q1 | $612K | Buy |
7,545
+653
| +9% | +$53K | 0.02% | 459 |
|
|
2017
Q4 | $615K | Buy |
6,892
+1,473
| +27% | +$131K | 0.02% | 454 |
|
|
2017
Q3 | $504K | Buy |
5,419
+891
| +20% | +$82.9K | 0.02% | 467 |
|
|
2017
Q2 | $411K | Buy |
4,528
+300
| +7% | +$27.2K | 0.02% | 495 |
|
|
2017
Q1 | $371K | Buy |
4,228
+882
| +26% | +$77.4K | 0.02% | 486 |
|
|
2016
Q4 | $277K | Sell |
3,346
-568
| -15% | -$47K | 0.01% | 488 |
|
|
2016
Q3 | $362K | Buy |
3,914
+859
| +28% | +$79.4K | 0.02% | 424 |
|
|
2016
Q2 | $238K | Buy |
+3,055
| New | +$238K | 0.01% | 439 |
|